|
EZSolution™ LDN193189
A potent BMP type I receptor inhibitor
Product Overview
Product Name: EZSolution™ LDN193189
Alternate Name/Synonyms: 6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine, hydrochloride; DM-3189
Description: A 10 mM (5 mg in 1.13 ml) solution of LDN193189 (Cat. No. 1995-5) in anhydrous DMSO.
Peptide Sequence: N/A
Appearance: Liquid
Formulation: A 10 mM solution in DMSO
CAS Number: 1062368-24-4 (free base)
Molecular Formula: C₂₅H₂₂N₆.HCl
Molecular Weight: 442.94
Purity: ≥97% by HPLC
Solubility:DMSO (10 mM)
Storage Temp.: -20°C
Shipping Conditions: gel pack
Handling: Protect from light and moisture
SMILES: C1CN(CCN1)C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3
InChi: InChI=1S/C25H22N6/c1-2-4-24-22(3-1)21(9-10-27-24)23-16-29-31-17-19(15-28-25(23)31)18-5-7-20(8-6-18)30-13-11-26-12-14-30/h1-10,15-17,26H,11-14H2
InChi Key: CDOVNWNANFFLFJ-UHFFFAOYSA-N
PubChem CID: 25195294
MDL Number: MFCD17169988
USAGE: For Research Use Only! Not For Use in Humans. |